Learning Objectives
Understand the pathogenesis and clinical markers of Idiopathic Pulmonary Fibrosis (IPF). Recognize the characteristic imaging findings, cellular shifts, and potential complications for the USMLE Step 1.
1. Pathogenesis and Etiology
IPF is a chronic, progressive fibrotic lung disease. While the exact cause is “idiopathic,” it is thought to result from repeated cycles of epithelial lung injury followed by aberrant wound healing and exuberant fibrosis.
| Risk Factor | Mechanism / Association |
|---|---|
| Tobacco Smoking | The most significant environmental risk factor. |
| Genetic Defects | Mutations in Telomerase (TERT, TERC) or Surfactant proteins. |
| Environmental | Exposure to metal dust, wood dust, or pollutants. |
2. Clinical Findings and Imaging
Patients typically present in their 50s or 60s with a gradual onset of symptoms that mimic heart failure or other interstitial lung diseases.
| Clinical Feature | Imaging / Physical Exam Sign |
|---|---|
| Symptoms | Progressive dyspnea, fatigue, and dry (nonproductive) cough. |
| Auscultation | Fine, “Velcro-like” end-expiratory crackles. |
| Physical Exam | Digital clubbing (suggests chronic hypoxemia). |
| CT Findings | “Honeycomb” appearance (subpleural cysts) and traction bronchiectasis. |
3. Histology: Usual Interstitial Pneumonia (UIP)
The characteristic histologic pattern for IPF is known as UIP. It is defined by “spatial and temporal heterogeneity”—areas of dense fibrosis alternating with normal lung. L
| Cellular Change | Status | Significance |
|---|---|---|
| Type 1 Pneumocytes | Decreased ( ) |
Lost due to repeated alveolar injury. |
| Type 2 Pneumocytes | Increased ( ) |
Hyperplasia is an attempt to repair the basement membrane. |
| Fibroblasts | Increased () |
Formation of “fibroblastic foci” that secrete excessive collagen. |
Activity:
4. Complications
As the architecture of the lung is destroyed, the pulmonary vasculature is compromised, leading to systemic effects.
| Complication | Mechanism |
|---|---|
| Pulmonary HTN | Vascular remodeling and chronic hypoxic vasoconstriction. |
| Cor Pulmonale | Right heart failure secondary to pulmonary hypertension. |
| Lung Cancer | Fibrosis and chronic inflammation increase the risk of malignancy. |
Activity:
Activity
High-Yield Clinical Pearls:
- Traction Bronchiectasis: This occurs because the surrounding fibrosis pulls the airways open, unlike obstructive bronchiectasis, where the airways dilate due to infection/mucus.
- Pirfenidone & Nintedanib: These are the two primary antifibrotic drugs used to slow the progression of IPF.
- PFT Pattern: Classic restrictive pattern (
, and
).